Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 43, Issue 1, 1999, Pages 49-58

  Tayama, Kazumi ^a   Inukai, Toshihiko ^a   Shimomura, Yohnosuke ^b  

^a Koshigaya Hospital   (Japan)

^b Gunma Prefectural College of Health Sciences   (Japan)

Author keywords

Diabetic Triopathy; Insulin; Leptin; NIDDM; Visceral fat

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ECHOGRAPHY; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ALBUMINURIA; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FASTING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LEPTIN; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERITONEUM; PROTEINS; REFERENCE VALUES; SENSATION; SKIN; TIME FACTORS;

EID: 0033012498     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00118-1     Document Type: Article

References (29)

1. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
2. Kaplan N.M. The deadly quartet: upper body obesity, glucose intolerance, hypertriglycedemia, and hypertension. Arch. Int. Med. 149:1989;1514-1520.
3. DeFronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diab. Care. 14:1991;173-194.
4. Matsuzawa Y., Fujioka S., Tokunaga K., Tarui S. Classification of obesity with respect to morbidity. Proc. Soc. Exp. Biol. Med. 200:1992;197-201.
5. Suzuki R., Watanabe S., Hirai Y., Akiyama K., Nishide T., Matsushima Y., Murayama H., Ohshima H., Shinomiya M., Shirai K., Saito Y., Yoshida S., Saisho H., Ohto M. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am. J. Med. 95:1993;309-314.
6. Matthews D.R., Hosker J.P., Rudenski A.S. Homeostasis model assessment; insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
7. Dua A., Hennes M.I., Hoffmann R.G., Maas D.L., Krakower G.R., Sonnenberg G.E., Kissebah A.H. Leptin: a significant indicator of total body fat not but of visceral fat and insulin insensitivity in African-American women. Diabetes. 45:1996;1635-1637.
8. Feldt-Rasmussen B., Dinesen B., Decker M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand. J. Clin. Lab. Invest. 45:1985;539-544.
9. Yamashita S., Nakamura T., Shimomura I., Nishida M., Yoshida S., Kotani K., Kameda-Takemura K., Tokunaga K., Matsuzawa Y. Insulin resistance and body fat distribution: contribution of visceral fat accumulation to the development of insulin resistance and atherosclerosis. Diab. Care. 19:1996;287-291.
10. Ryan A.S., Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptins: Its relationships with body fat, visceral adiposity, and age in women. J. Clin. Endcrinol. Metab. 81:1996;4433-4438.
11. Nyholm B., Fisker S., Lund S., Moller N., Schmitz O. Increased circulating leptin concentrations in insulin-resistant first degree relatives of patients with non-insulin-dependent diabetes mellitus: relationship to body composition and insulin sensitivity but not to family history of non-insulin-dependent diabetes mellitus. Eur. J. Endocrinol. 136:1997;173-179.
12. Malmstrom R., Taskinen M.R., Karonen S.L., Jarvinen H.Y. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia. 39:1996;993-996.
13. Schwartz M.W., Prigeon R.L., Kahn S.E., Nicolson M., Moore J., Morawiecki A., Boyko E.J, Porte E. Evidence that plasma leptin and insulin levels are associated with body adiposity via differential mechanisms. Diab. Care. 20:1997;16-1481.
14. Kolaczynski J.W., Nyce M.R., Considine R.V., Boden G., Nolan J.J., Henry R., Mudaliar S.R., Olefsky J., Caro J.F. Acute and chronic effect of insulin on leptin production in humans. Diabetes. 45:1996;699-701.
15. Boyko E.J., Leonetti D.L., Bergstrom R.W., Newell-Morris L., Fujimoto W.J. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity: 5-year follow-up among initially non diabetic Japanese-American men. Diabetes. 45:1996;1010-1015.
16. Goodpaster B.H., Thaete F.L., Simoneau J.A., Kelley D.E. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independency of visceral fat. Diabetes. 46:1997;1579-1585.
17. Haffner S.M., Hanefeld M., Fischer S., Fucker K., Leonharld W. Glibenclamide, but not acarbose, increases leptin concentrations parallel to changes in insulin in subjects with NIDDM. Diab. Care. 20:1997;1430-1434.
18. Groop L., Widen E., Franssila-Kallunki A., Ekstrand A., Saloranta C., Schalin C., Eriksson J. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 32:1989;599-605.
19. Taylor R. Insulin for the non-insulin dependent? Br. Med. J. 296:1988;1015-1016.
20. Benerji M.A., Lebowitz J., Chaiken R.L., Gordon D., Kral J.G., Lebowitz H.E. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am. J. Physiol. 273:1997;E425-E432.
21. Bjorntorp P. Regional obesity and NIDDM. Adv. Exp. Med. Biol. 334:1993;279-285.
22. Snehalatha C., Ramachandran A., Satyabani K., Vallabi M.Y., Viswanathan V. Computed axial tomographic scan measurement of abdominal fat distribution and its correlation with anthropometry and insulin secretion in healthy Asian Indians. Metabolism. 46:1997;1220-1224.
23. Macor C., Ruggeri A., Mazzonetto P., Federspil G., Cobelli C., Vettor R. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. Metabolism. 46:1997;123-129.
24. Kanai H., Matsuzawa Y., Kotani K., Keno Y., Kobatake T., Nagai Y., Fujioka S., Tokunaga K., Tarui S. Close correlation of intra-abdominal fat accumulation to hypertension in obese women. Hypertension. 16:1990;484-490.
25. Fujioka S., Matsuzawa Y., Tokunaga K., Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 36:1987;54-59.
26. Inui Y., Kawata S., Matsuzawa Y., Tokunaga K., Fujioka S., Tamura S., Kobataka T., Keno Y., Tarui S. Increased level of apoprotein B mRNA in the liver of ventromedial hypothalamus lesioned obese rats. Biochem. Biophys. Res. Commun. 163:1989;1107-1112.
27. 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia. 40:1997;200-204.
28. Commuzzie A.G., Hixson J.E., Almasy L., Mitchell B.D., Mahaney M.C., Dyer T.D., Stem M.P., MacCluer J.W., Blangero J. A major quantitative trait locus detemming serum leptin levels and fat mass is located on human chromosome 2. Nat. Genet. 15:1997;273-276.
29. Rebuffe-Scrive M., Surwit R., Feinglos M., Kuhn C., Rojin J. regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism. 45:1996;1119-1124.